Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study

Alcohol Drinking Clinical Trial

Official title:

Effects of Stereotype Threat on Impulsivity and Its Relation to Alcohol Use in African Americans: An fMRI Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05675332
• Other study ID #: GCO 19-0250
• Secondary ID: R01AA028023
• Status: Recruiting
• Phase: N/A
• Start date: December 9, 2022
• Est. completion date: January 31, 2026

Study information

• Verified date: February 2024
• Source: Icahn School of Medicine at Mount Sinai
• Contact: Shivani Doshi
• Phone: 212-241-6582
• Email: shivani.doshi[@]mssm.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to investigate the behavioral and neural correlates of stress exposure. Results from this study will enrich the understanding of how sociocultural, behavioral, and neural factors combine to influence alcohol use.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 280
• Est. completion date: January 31, 2026
• Est. primary completion date: January 31, 2026
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 21 Years to 35 Years

Eligibility

Inclusion Criteria:

• Between 21 and 35 years of age (inclusive);
• Fluent in English;
• Right-handed

Exclusion Criteria:

• Younger than 21 years of age;
• Left-handed

Related Conditions & MeSH terms

• Alcohol Drinking
• Impulsive Behavior

Intervention

Behavioral:
• Task-based behavioral intervention
Brief behavioral intervention is absent of stressors.
• Task-based behavioral intervention
Brief behavioral intervention involves interacting with common everyday types of stress.

Locations

Country	Name	City	State
United States	Icahn School of Medicine at Mount Sinai	New York	New York

Sponsors (2)

Lead Sponsor	Collaborator
Icahn School of Medicine at Mount Sinai	National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Blood oxygen-level dependent (BOLD) signal	Blood oxygen-level dependent (BOLD) signal in brain regions of interest (ROI) measured using fMRI	Baseline
Primary	Resting-state functional connectivity in brain regions	Resting-state functional connectivity - brain activity measured using fMRI	Baseline